10x Genomics, Inc.
TXG
$20.92
$0.422.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 60.80% | 66.85% | 23.16% | 191.14% | 42.69% |
| Total Depreciation and Amortization | 24.12% | 14.54% | 13.96% | -11.46% | -30.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.88% | -20.37% | -20.76% | -29.44% | -16.96% |
| Change in Net Operating Assets | -81.30% | 1,450.15% | 144.54% | -1,220.76% | 549.10% |
| Cash from Operations | -23.96% | 704.28% | 99.69% | 136.23% | 318.45% |
| Capital Expenditure | 15.64% | 34.57% | 82.33% | 45.17% | 34.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 101.28% | 85.24% | -95.69% | -- |
| Cash from Investing | 30.74% | 96.50% | -143.26% | -107.86% | -117.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -35.31% | -50.37% | 295.51% | -23.48% | -74.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2,094.55% | -50.37% | 295.51% | -23.48% | -74.24% |
| Foreign Exchange rate Adjustments | -164.04% | 115.99% | -121.15% | 12,100.00% | 337.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -50.54% | 176.27% | 90.88% | -14.11% | 1,041.88% |